Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -60.41% is 60% above its 5-year average of -150.78%, near the high end of its 5-year range (-3335.59%–-27.40%).
As of the fiscal period ended Friday, July 31, 2026. 60.12% above its 12-month average of -151.49%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-07-31): -60.41%.
RETURN ON INVESTED CAPITAL (ROIC)
-60.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-151.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-125.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-150.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+60.12%
CURRENT VS 3Y AVG
+51.89%
CURRENT VS 5Y AVG
+59.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.25%
median of 439 covered companies
CURRENT VS SECTOR MEDIAN
-121.69%
vs the sector median at left
Clearmind Medicine Inc.
Market Cap
$1.11M
Return on Invested Capital (ROIC)
-60.41%
TTM Avg
-151.49%
3Y Avg
-125.56%
5Y Avg
-150.78%
Market Cap
$1.14M
Return on Invested Capital (ROIC)
-9.45%
TTM Avg
-4.19%
3Y Avg
5.39%
5Y Avg
5.39%
Market Cap
$1.17M
Return on Invested Capital (ROIC)
-128.95%
TTM Avg
-69.60%
3Y Avg
-67.51%
5Y Avg
-50.89%
Market Cap
$1.02M
Return on Invested Capital (ROIC)
-59.81%
TTM Avg
-3.58%
3Y Avg
-5.96%
5Y Avg
-5.96%
Market Cap
$888387.00
Return on Invested Capital (ROIC)
-343.55%
TTM Avg
-272.49%
3Y Avg
-270.70%
5Y Avg
-191.72%
Market Cap
$885939.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-416.12%
3Y Avg
-338.16%
5Y Avg
-243.59%
Market Cap
$878396.00
Return on Invested Capital (ROIC)
-78.01%
TTM Avg
-90.63%
3Y Avg
-141.82%
5Y Avg
-116.81%
Market Cap
$1.36M
Return on Invested Capital (ROIC)
-219.36%
TTM Avg
-214.97%
3Y Avg
-160.97%
5Y Avg
-133.06%
Market Cap
$1.37M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-750.62%
3Y Avg
-506.81%
5Y Avg
-355.90%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clearmind Medicine Inc. (CMND) | $1.11M | -60.41% | -151.49% | -125.56% | -150.78% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | -9.45% | -4.19% | 5.39% | 5.39% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -128.95% | -69.60% | -67.51% | -50.89% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -59.81% | -3.58% | -5.96% | -5.96% |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | -343.55% | -272.49% | -270.70% | -191.72% |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | N/A | -416.12% | -338.16% | -243.59% |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | -78.01% | -90.63% | -141.82% | -116.81% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | -219.36% | -214.97% | -160.97% | -133.06% |
| Genprex, Inc. (GNPX)vs › | $1.37M | -107.08% | -750.62% | -506.81% | -355.90% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | -77.55% | -118.09% | -161.88% | -137.96% |
ROIC
-60.4%
ROE
-57.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-07-31 | -60.41% |
| 2026-04-30 | -70.16% |
| 2026-01-31 | -95.09% |
| 2025-10-31 | -136.95% |
| 2025-07-31 | -394.83% |
| 2025-04-30 | -184.33% |
| 2025-01-31 | -138.91% |
| 2024-10-31 | -132.12% |
| 2024-07-31 | -120.83% |
| 2024-04-30 | -86.43% |
| 2024-01-31 | -85.72% |
| 2023-10-31 | -640.04% |
| 2023-07-31 | -270.23% |
| 2023-04-30 | -249.60% |
| 2023-01-31 | -177.89% |
| 2022-07-31 | -3335.59% |
| 2022-04-30 | -613.84% |
| 2022-01-31 | -238.38% |
| 2021-10-31 | -93.99% |
| 2021-07-31 | -27.40% |
| 2021-04-30 | -26.15% |
| 2021-01-31 | -93.92% |
| 2020-10-31 | -61.39% |
| 2020-07-31 | -42.26% |
| 2020-04-30 | -29.68% |
| 2020-01-31 | -130.92% |
| 2019-10-31 | -102.75% |
| 2019-07-31 | -233.76% |
| 2019-04-30 | -212.27% |
| 2019-01-31 | -150.28% |
| 2018-10-31 | -141.24% |
| 2018-07-31 | -42.01% |
